Precision BioSciences
(NASDAQ) DTIL
Precision BioSciences Financials at a Glance
Market Cap
$159.20M
Revenue (TTM)
$45.07M
Net Income (TTM)
-$44.49M
EPS (TTM)
-$3.72
P/E Ratio
-1.66
Dividend
$0.00
Beta (Volatility)
1.34 (Average)
Dividend
$0.00
Beta (Volatility)
1.34 (Average)
Price
$6.17
Volume
432,210.597
Open
$6.66
Price
$6.17
Volume
432,210.597
Open
$6.66
Previous Close
$6.17
Daily Range
$6.03 - $6.66
52-Week Range
$3.53 - $8.82
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
1.34 (Average)
Price
$6.17
Volume
432,210.597
Open
$6.66
Previous Close
$6.17
Daily Range
$6.03 - $6.66
52-Week Range
$3.53 - $8.82
Estimated Earnings Date
Aug 6, 2026
DTIL News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Precision BioSciences
Industry
Biotechnology
Sector
Health CareEmployees
66
CEO
Michael Amoroso, EMBA
Website
www.precisionbiosciences.comHeadquarters
Durham, NC 27701, US
DTIL Financials
Key Financial Metrics (TTM)
Gross Margin
97%
Operating Margin
-87%
Net Income Margin
-99%
Return on Equity
-71%
Return on Capital
-29%
Return on Assets
-31%
Earnings Yield
-60.24%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$159.20M
Shares Outstanding
25.80M
Volume
432.21K
Avg. Volume
319.19K
Financials (TTM)
Gross Profit
$31.51M
Operating Income
-$52.15M
EBITDA
-$42.43M
Operating Cash Flow
-$65.84M
Capital Expenditure
-$85.00K
Free Cash Flow
-$65.93M
Cash & ST Invst.
$115.59M
Total Debt
$28.81M
Precision BioSciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$10.84M
+37272.4%
Gross Profit
$10.84M
+37272.4%
Gross Margin
100.00%
N/A
Market Cap
$159.20M
N/A
Market Cap/Employee
$1.47M
N/A
Employees
108
N/A
Net Income
-$18.44M
+10.3%
EBITDA
-$17.49M
+10.3%
Quarterly Fundamentals
Total Cash
$101.18M
+31.0%
Total Debt
$28.47M
-4.3%
Accounts Receivable
$4.00M
+99900.0%
Inventory
$0.00
N/A
Long Term Debt
$26.91M
-5.2%
Short Term Debt
$1.56M
+14.1%
Return on Assets
-30.92%
N/A
Return on Invested Capital
-28.73%
N/A
Free Cash Flow
-$11.96M
+38.3%
Operating Cash Flow
-$11.94M
+37.3%